The SHARON Trial

Sharon Seibel was surprised and devasted by her diagnosis of pancreatic cancer.

Despite a family history of ovarian cancer and a BRCA mutation, she was unaware of the relationship with pancreatic cancer. After radiation and Whipple procedure, Sharon discovered she would need more treatment. Her brother, a cancer researcher, helped develop a novel approach, which Sharon took, as the first person with pancreatic cancer to try this. A modified version of this drug is used in the SHARON trial, and Sharon herself is here 13 years later to share her story.

Read more about Sharon in “My BRCA2 Mutation Turned Out to Be Both the Curse and the Cure.”